biotech · Essential Tremor · Systemic Lupus Erythematosus
Chongqing Precision Biotech
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech is a biotech organization headquartered in Chongqing, CN. Primary therapeutic focus areas include Essential Tremor, Systemic Lupus Erythematosus, Focal Epilepsy, Multiple Myeloma, Colorectal C
重庆市创业大道高科创业园A栋, Chongqing, CN HQ
2016 Founded
5 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 重庆市创业大道高科创业园A栋, Chongqing, CN
- Founded
- 2016
- Employees
- 5
- Programs
- 109
- Drugs
- 57
- Patents
- 158
CD19 and CD22 targeted prime CAR- T cells
Phase 2 · mab · B Cell Lymphoma
CD19 and CD22 targeted prime CAR- T cells for B Cell Lymphoma is a Phase 2 program (mab) at Chongqing Precision Biotech Co., Ltd with 1 ClinicalTrials.gov record(s).
Internal code PBC026
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Chongqing Precision Biotech Co., Ltd
- Phase
- Phase 2
- Modality
- mab
- Indication
- B Cell Lymphoma
- Status
- active
- Trials
- 1